The Italian Journal of Neurological Sciences

, Volume 15, Issue 9, pp 481–488 | Cite as

Cognitive impairment and quality of life in long-term survivors of malignant brain tumors

  • Giovagnoli A. R. 
  • Boiardi A. 
Original Articles

Abstract

Thirtysix long-term survivors following the treatment of a malignant supratentorial brain tumor were examined for cognitive functions and global level of autonomy. Eighteen patients were symptom-free (SF) and 18 had clinical and neuroradiological recurrence (RE). The control group included 30 healthy subjects. All subjects underwent a neuropsychological battery for general and specific cognitive functions. The level of autonomy was assessed by means of the Karnofsky Performance Scale (KPS) for oncological patients. SF patients showed less impairment than RE patients both at the tests, as well as on the KPS. The cognitive deficits were subclinical in most SF patients, the tests for attention, memory and word fluency being the most sensitive in detecting subtle dysfunctions. The association between tumor location and specific cognitive deficits was inconstant in both patient groups. The results suggest that even subtle cognitive deficits can prevent SF long-term survivors from returning to premorbid autonomy and occupations, and that neuropsychological tests may be used as complementary routine indicators of their quality of life. Furthermore, our data show that, in selected patients, combined treatments and therapeutic insistence do not necessarily have the same deleterious effects.

Key Words

malignant brain tumor long-term survival symptom-free patients cognitive impairment quality of life 

Sommario

Trentasei pazienti, lungosopravviventi dopo il trattamento per un tumore sopratentoriale maligno, sono stati sottoposti ad und valutazione delle funzioni cognitive e del livello globale di autonomia. Diciotto pazienti erano asintomatici e 18 presentavano recidiva clinica e radiologica. Come gruppo di controllo sono stati esaminati 30 soggetti sani. Tutti i soggetti sono stati sottoposti ad una batteria neuropsicologica per la valutazione di funzioni cognitive generali e specifiche. Il livello di autonomia è stato definito mediante la scala di Karnofsky per pazienti oncologici. I pazienti asintomatici hanno mostrato una minore compromissione sia delle funzioni cognitive che del livello di autonomia rispetto a quelli con recidiva. I deficit cognitivi sono risultati modesti nella maggior parte dei pazienti asintomatici ed i test di attenzione, fluenza verbale e memoria sono apparsi i più sensibili nel rilievo di disfunzioni subcliniche. L'associazione tra sede del tumore e deficit cognitivi specifici è risultata incostante in entrambi i gruppi di pazienti. I risultati suggeriscono che deficit cognitivi anche lievi possono impedire il completo recupero dell'autonomia e delle attività premorbose nei lungosopravviventi asintomatici e che i test neuropsicologici possono fornire indici complementari nella valutazione routinaria della qualità di vita. I nostri dati inoltre mostrano che, in pazienti selezionati, l'insistenza terapeutica non induce necessariamente effetti deleteri.

References

  1. [1]
    Anderson S.W., Damasio H., Tranel D.:Neuropsychological impairments associated with lesions caused by tumor or stroke. Arch. Neurol. 47:397–405, 1990.PubMedGoogle Scholar
  2. [2]
    Arrigoni C., De Renzi E.:Constructional apraxia and hemisphere locus of lesion. Cortex 1:170–197, 1964.Google Scholar
  3. [3]
    Basso A., Capitani E., Laiacona M.:Raven's coloured progressive matrices: normative values on 305 adult normal controls. Funct. Neurol. 2:189–194, 1987.PubMedGoogle Scholar
  4. [4]
    Benton, L.A., Hamsher K., Verney N.R.:Judgement of line orientation. In: Benton L.A., Hamsher K., Verney N.R. (Eds.): Contribution to neuropsychological assessment, Otfried Spreen, pp. 44–54, 1983.Google Scholar
  5. [5]
    Benton L.A.:Some problems associated with neuropsychological assessment. Bull. Clin. Neurosci. 50:11–15, 1985.PubMedGoogle Scholar
  6. [6]
    Bornstein R.A.:Classification rates obtained with standard cut-off scores on selected neuropsychological measures. J. Clin. Exper. Neuropsychol. 8:413–420, 1986.Google Scholar
  7. [7]
    Cavazzuti V., Fisher E.G., Welch K., Belli J.A., Winston K.R.:Neurological and psychological sequaele following different treatments of craniopharyngioma in children. J. Neurosurg. 59:409–417, 1983.PubMedGoogle Scholar
  8. [8]
    Crossen J.R., Goldman D.L., Dahlborg S.A.N., Neuwelt E.A.:Neuropsychological assessment outcomes of nonaquired immunodeficiency syndrome patients with primary central nervous system lymphoma before and after blood-brain barrier disruption chemotherapy. Neurosurgery 30:23–29, 1992.PubMedGoogle Scholar
  9. [9]
    Damasio A.R., Geshwind N.:Anatomical localization in clinical neuropsychology. In: Vinken P.J., Bruyn G.W., Klawans H.L. (Eds.): Handbook of clinical neurology, vol. 45: Clinical neuropsychology, Elsevier Publishers, pp. 7–22, 1985.Google Scholar
  10. [10]
    De Angelis L.M., Delattre J.K., Posner J.B.:Radiation-induced dementia in patients cured of brain metastases. Neurology 39:789–796, 1989.Google Scholar
  11. [11]
    De Renzi E.:Disorders of space exploration and cognition. New York: John Wiley and Sons 1982.Google Scholar
  12. [12]
    De Renzi, Vignolo L.A.:The Token test: a sensitive test to detect receptive disturbances in aphasia. Brain 85:665–678, 1962.Google Scholar
  13. [13]
    Donovan K., Samson-Fisher R.W., Redman S.:Measuring quality of life in cancer patients. J. Clin. Oncol. 7:959–968, 1989.PubMedGoogle Scholar
  14. [14]
    Fleck J.D., Einhorn L.J., Lauer R.C., Schultz S.M., Miller M.R.:Is prophylactic cranial irradiation in small-cell lung cancer? J. Clin. Oncol. 8:209–214, 1990.PubMedGoogle Scholar
  15. [15]
    Hochberg F.H., Slotnick B.:Neuropsychological impairment in astrocytoma survivors. Neurology 30:172–177, 1980.PubMedGoogle Scholar
  16. [16]
    Iimperato J.P., Paleologos N.A., Vich N.A.:Effects of treatment on long-term survivors with malignant astrocytomas. Ann. Neurol. 28:818–822, 1990.Google Scholar
  17. [17]
    Johnson B.E., Becker B., Goff W.B., et al.:Neurologic, neuropsychologic and computed cranial tomography scan abnormalities in 2− to 10− year survivors of small-cell lung cancer. J. Clin. Oncol. 3:1659–1667, 1985.PubMedGoogle Scholar
  18. [18]
    Karnofsky D.A., Abelmann W.H., Craver L.F., et al.:The use of nitrogen mustards in the palliative treatment of carcinoma. Cancer 1:634–656, 1948.Google Scholar
  19. [19]
    Karnofsky D.A., Burchenal J.H.:The clinical evaluation of chemotherapeutic agents in cancer. In: MacLeod C.M., (Ed.): Evaluation of chemotherapeutic agents. New York: Columbia University Press, pp. 191–205, 1949.Google Scholar
  20. [20]
    Lee Y.Y., Nanert C., Glass J.P.:Treatment-related white matter changes in cancer patients. Cancer 57:1473–1482, 1986.PubMedGoogle Scholar
  21. [21]
    Lieberman A.N., Foo S.H., Ranshoff J. et al.:Long-term survival among patients with malignant brain tumors. Neurosurgery 10:450–453, 1982.PubMedGoogle Scholar
  22. [22]
    Mackworth N., Fobair P., Prados M.D.:Quality of life self-reports from 200 brain tumor patients: comparisons with Karnofsky performance scores. J. Clin. Oncol. 14:243–253, 1992.Google Scholar
  23. [23]
    Marie J., Coudin B., Guerin J., Caudry M.:Neuropsychological impairment in adults with brain tumors. Am. J. Clin. Oncol. 10:156–162, 1987.Google Scholar
  24. [24]
    Mostow E.N., Byrne J., Connelly R.R., Mulvihill J.J.:Quality of life in long-term survivors of CNS tumors of childhood and adolescence. J. Clin. Oncol. 9:592–599, 1991.PubMedGoogle Scholar
  25. [25]
    Mulhern R.H., Kun E.:Neuropsychological functions in children with brain tumors: III. Interval changes in the six months following treatment. Med. Ped. Oncol. 13:318–324, 1985.Google Scholar
  26. [26]
    Schag C.C., Heinrich R.L., Ganz P.A.:Karnofsky performance scale revisited: reliability, validity and guidlines. J. Clin. Oncol. 2:187–193, 1984.PubMedGoogle Scholar
  27. [27]
    Sichez N., Fauchon F., Chantelard J.V., et al:Quality of life in long term survivors of astrocytomas treated with surgery and radiation therapy: a neuropsychological study. Abstract II Meeting European Neurological Society, p. S2, 1990.Google Scholar
  28. [28]
    Spinnler H., Tognoni G.:Standardizzazione e taratura italiana di test neuropsicologici. It. J. Neurol. Sci., suppl. 8, 1987.Google Scholar
  29. [29]
    Tannock I., Murphey K.:Reflectionon medical oncology: an appeal for better clinical trials and improved reporting of their results. J. Clin. Oncol. 1:66–70, 1983.PubMedGoogle Scholar
  30. [30]
    Vilkki J.:Differential perseverations in verbal retrieval related to anterior and posterior left hemisphere lesions.Brain Language 36:543–554, 1989.Google Scholar
  31. [31]
    Yates J.W., Chalmer, B., McKegney F.P.:Evaluation of patients with advanced cancer using the Karnofsky performance status. Cancer 40:2220–2224, 1980.Google Scholar

Copyright information

© Masson S.p.A. 1994

Authors and Affiliations

  • Giovagnoli A. R. 
    • 1
  • Boiardi A. 
    • 1
  1. 1.Istituto Nazionale Neurologico “C. Besta”Milano

Personalised recommendations